Related Experiment Video
Updated: May 6, 2026

12:59
Barnes Maze Testing Strategies with Small and Large Rodent Models
Published on: February 26, 2014
41.9K
Gene-Dose-Dependent Reduction Fshr Expression Improves Spatial Memory Deficits in Alzheimer's Mice
Tal Frolinger1, Funda Korkmaz1, Steven Sims1
1Icahn School of Medicine at Mount Sinai.
Research Square
|March 11, 2024
Summary
Inhibiting follicle-stimulating hormone (FSH) signaling protected against cognitive decline and memory loss in mouse models of Alzheimer's disease (AD). Genetic depletion of FSH receptors (Fshr) prevented spatial and recognition memory deficits, suggesting a therapeutic target for AD prevention.
Area of Science:
- Neuroscience
- Endocrinology
- Genetics
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder linked to aging.
- Elevated post-menopausal follicle-stimulating hormone (FSH) levels correlate with AD onset.
- FSH directly activates hippocampal FSH receptors (Fshr), driving AD pathology and memory loss in mice.
Approach:
- Used female 3xTg mice with varying Fshr gene dosages (Fshr+/+, Fshr+/-, Fshr-/-).
- Administered ovariectomy or sham surgery, with estradiol normalization in some groups.
- Assessed spatial and recognition memory using Morris Water Maze and Novel Object Recognition tests.
Key Points:
- Fshr depletion dose-dependently prevented spatial memory impairment in 3xTg mice.
- Deletion of Fshr protected against age-related progression of spatial memory deficits.
- Recognition memory loss was prevented by Fshr deletion, except in ovariectomized mice.
- Amyloid β40 levels were reduced in a gene-dose-dependent manner with Fshr depletion.
- Low serum FSH levels correlated with better spatial memory retrieval in aged APP/PS1 mice.
Conclusions:
- Genetic evidence supports a protective role for inhibiting FSH signaling in memory deficits.
- FSH receptor signaling contributes to AD-like cognitive decline and pathology.
- Targeting FSH signaling offers a potential strategy for early prevention of cognitive decline in postmenopausal women.

